Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Chimerix Inc (NQ: CMRX )

1.421 +0.031 (+2.26%)
Streaming Delayed Price Updated: 2:43 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 529,894
Open 1.480
Bid (Size) 1.420 (16)
Ask (Size) 1.430 (28)
Prev. Close 1.390
Today's Range 1.400 - 1.480
52wk Range 1.090 - 2.898
Shares Outstanding 86,249,744
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
7 Deeply Undervalued Growth Stocks to Buy in June
Investors may see significant rewards betting on these best undervalued growth stocks for June. 
Via InvestorPlace
Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference
From Chimerix, Inc.
Via GlobeNewswire

Performance

YTD
-23.99%
-23.99%
1 Month
+24.68%
+24.68%
3 Month
-15.89%
-15.89%
6 Month
-39.51%
-39.51%
1 Year
-21.03%
-21.03%

More News

Read More
Chimerix to Participate in Cancer Moonshot Brain Cancers Forum on Glioblastoma (GBM) and Diffuse Intrinsic Pontine Glioma (DIPG) at White House
From Chimerix, Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2023
Via Benzinga
A Look Into Healthcare Sector Value Stocks
Via Benzinga
Chimerix Earnings Preview
Via Benzinga
Chimerix Reports First Quarter 2023 Financial Results and Provides Operational Update
From Chimerix, Inc.
Via GlobeNewswire
Chimerix to Report First Quarter 2023 Financial Results and Provide an Operational Update on May 4, 2023
From Chimerix, Inc.
Via GlobeNewswire
Chimerix Announces Presentation of Multiple Imipridone Datasets at American Association for Cancer Research Annual Meeting
From Chimerix, Inc.
Via GlobeNewswire
7 Thrilling Biotech Stocks for Aggressive Investors to Buy
Via InvestorPlace
Looking Into Chimerix's Return On Capital Employed
Via Benzinga
Chimerix's Earnings Outlook
Via Benzinga
Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank
Via Benzinga
Sunrun Down Over 10% On Silicon Valley Bank Exposure: What Other Companies Are Exposed?
Via Benzinga
The Top 7 Growth Stocks in Biotech
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Chimerix Reports Fourth Quarter and Year End 2022 Financial Results and Provides Operational Update
From Chimerix, Inc.
Via GlobeNewswire
Chimerix to Present at Cowen and Company 43rd Annual Health Care Conference
From Chimerix, Inc.
Via GlobeNewswire
Chimerix to Report Fourth Quarter and Year End 2022 Financial Results and Provide an Operational Update on March 2, 2023
From Chimerix, Inc.
Via GlobeNewswire
7 Overlooked Value Stocks That Could Outperform the Market
Via InvestorPlace
The 7 Best Biotech Stocks to Buy for February 2023
Via InvestorPlace
The 7 Most Undervalued Biotech Stocks to Buy in February 2023
Via InvestorPlace
Chimerix to Present at 41st Annual J.P. Morgan Healthcare Conference
From Chimerix, Inc.
Via GlobeNewswire
Chimerix Announces Successful Launch of ONC201 Phase 3 ACTION Study at Society for Neuro-Oncology Conference and Provides Operational Update
From Chimerix, Inc.
Via GlobeNewswire
Chimerix Responds to Rubric Capital Management
From Chimerix, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.